Allergists offer reassurance regarding potential allergic reactions to COVID-19 vaccines
A team led by Massachusetts General Hospital stresses that people with food or medication allergies can safely be vaccinated.
Safe Care CommitmentGet the care you need even during COVID-19.Learn more
Dr. Banerji is an Associate Professor at Harvard Medical School and Clinical Director of the Allergy and Clinical Immunology Unit at MGH. Dr. Banerji is an Allergist and Immunologist with a special interest in drug allergy and angioedema. She has a national reputation as an expert in these fields, with invited talks in both areas at regional, national and international conferences. Dr. Banerji has built a formal drug allergy program in the outpatient allergy clinic at MGH to better manage patients with drug hypersensitivity reactions. She leads the inpatient desensitization program for patients with reactions to chemotherapeutics and monoclonal antibodies. As part of this drug allergy program, she collects standardized data on all patients we evaluate for drug hypersensitivity in order to identify risk factors for true hypersensitivity and improve drug allergy diagnosis with skin testing and challenges. In 2013, Dr. Banerji was invited to participate in an NIH workshop geared towards developing a prioritized research agenda on drug allergy and a summary of this meeting was published in August 2015 in the Journal of Allergy and Clinical Immunology. As an angioedema expert, Dr Banerji has collaborated with industry on multiple novel agents for hereditary angioedema and has published >50 peer-reviewed manuscripts including national and international guidelines for the management of angioedema. Dr. Banerji has actively participated as an investigator on multiple large clinical trials in hereditary angioedema, several of which were investigator initiated studies and including one study published by the NEJM in 2017 and another in JAMA in 2019 as a first author.
Clinical Interests:
Treats:
Allergy Associates
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-726-3850
Fax: 617-724-0239
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
View my most recent publications at PubMed
Dr. Banerji's work focuses on drug allergy and angioedema. Specifically, Dr. Banerji has worked on improving the diagnosis and management of patients presenting with drug reactions to a variety of medications including antibiotics, aspirin, chemotherapeutic agents, monoclonal antibiotics and anesthetic agents. In the field of angioedema, Dr. Banerji has a particular interest in hereditary angioedema to improving care, improve quality of life and decreasing burden of disease.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.
A team led by Massachusetts General Hospital stresses that people with food or medication allergies can safely be vaccinated.
A phase 3 clinical trial led by a Massachusetts General Hospital physician, finds that injections of the monoclonal antibody drug lanadelumab reduced attacks of hereditary angioedema – a rare, potentially life-threatening disorder.